1. Home
  2. TRLV vs LBRX Comparison

TRLV vs LBRX Comparison

Compare TRLV & LBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trulieve Cannabis Corp. Subordinate Voting Shares

TRLV

Trulieve Cannabis Corp. Subordinate Voting Shares

N/A

Current Price

$12.16

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Logo LB Pharmaceuticals Inc

LBRX

LB Pharmaceuticals Inc

HOLD

Current Price

$48.97

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRLV
LBRX
Founded
N/A
2015
Country
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
TRLV
LBRX
Price
$12.16
$48.97
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$46.60
AVG Volume (30 Days)
1.2M
285.4K
Earning Date
N/A
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
26.58
98.22
EPS
N/A
N/A
Revenue
$1,181,180,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.82
$13.40
52 Week High
$12.28
$50.16

Technical Indicators

Market Signals
Indicator
TRLV
LBRX
Relative Strength Index (RSI) 71.33 56.39
Support Level $8.22 $21.90
Resistance Level N/A $49.65
Average True Range (ATR) 0.68 2.02
MACD 0.13 -0.53
Stochastic Oscillator 91.95 30.43

Price Performance

Historical Comparison
TRLV
LBRX

About TRLV Trulieve Cannabis Corp. Subordinate Voting Shares

Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.

About LBRX LB Pharmaceuticals Inc

LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases. It is building a pipeline that leverages the broad therapeutic potential of its product candidate, LB-102, which it believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is currently in late-stage clinical development for schizophrenia and bipolar depression. The company operates as a single reportable segment in the development of novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.

Share on Social Networks: